Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis
Language: 
English
Abstract: 

Autoimmune hepatitis is a severe immune mediated chronic liver disease with a prevalence range between 50 and 200 cases per million in Western Europe and North America and mortality rates of up to 80% in untreated patients. The induction of CB1 and CB2 cannabinoid receptors during liver injury and the potential involvement of endocannabinoids in the regulation of this process have sparked significant interest in further evaluating the role of cannabinoid systems during hepatic disease. Cannabinoids have been shown to possess significant immunosuppressive and anti-inflammatory properties. Cannabinoid abuse has been shown to exacerbate liver fibrogenesis in patients with chronic hepatitis C infection involving CB1 receptor. Nonetheless, CB2 receptor activation may play a protective role during chronic liver diseases. Thus, differential targeting of cannabinoid receptors may provide novel therapeutic modality against autoimmune hepatitis. In this review, we summarize current knowledge on the role of endocannabinoids and exocannabinoids in the regulation of autoimmune hepatitis.

Author(s): 
Pandey, Rupal
Hegde, Venkatesh L.
Singh, Narendra P.
Hofseth, Lorne
Singh, Uday
Ray, Swapan
Nagarkatti, Mitzi
Nagarkatti, Prakash S.
Item Type: 
Journal Article
Publication Title: 
Vitamins and Hormones
Journal Abbreviation: 
Vitam. Horm.
Publication Date: 
2009
Publication Year: 
2009
Pages: 
487-504
Volume: 
81
ISSN: 
0083-6729
DOI: 
10.1016/S0083-6729(09)81019-4
Library Catalog: 
NCBI Published Medical (?)
Extra: 
PMID: 19647124 PMCID: PMC4139007

Turabian/Chicago Citation

Rupal Pandey, Venkatesh L. Hegde, Narendra P. Singh, Lorne Hofseth, Uday Singh, Swapan Ray, Mitzi Nagarkatti and Prakash S. Nagarkatti. 2009. "Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis." Vitamins and Hormones 81: 487-504. 10.1016/S0083-6729(09)81019-4.

Wikipedia Citation

<ref> {{Cite journal | doi = 10.1016/S0083-6729(09)81019-4 | issn = 0083-6729 | volume = 81 | pages = 487-504 | last = Pandey | first = Rupal | coauthors = Hegde, Venkatesh L., Singh, Narendra P., Hofseth, Lorne, Singh, Uday, Ray, Swapan, Nagarkatti, Mitzi, Nagarkatti, Prakash S. | title = Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis | journal = Vitamins and Hormones | date = 2009 | pmid = | pmc = }} </ref>